Profile data is unavailable for this security.
About the company
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
- Revenue in USD (TTM)0.00
- Net income in USD-6.91m
- Incorporated2013
- Employees3.00
- LocationGalmed Pharmaceuticals Ltd16 Tiomkin StreetTEL AVIV-YAFO 6578317IsraelISR
- Phone+972 36938448
- Fax+972 36938447
- Websitehttps://www.galmedpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOHM Inc | -100.00bn | -100.00bn | 2.08m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| VG Life Sciences Inc | 0.00 | -4.30m | 2.11m | 7.00 | -- | -- | -- | -- | -0.0721 | -0.0721 | 0.00 | -0.0491 | 0.00 | -- | -- | -- | -384.41 | -294.08 | -- | -- | -- | -- | -- | -587,591.90 | -- | -1.70 | -- | -- | -- | -- | 16.58 | -- | -- | -- |
| Marijuana Company Of America Inc | 1.50m | -13.01m | 2.21m | 7.00 | -- | -- | -- | 1.47 | -0.0071 | -0.0071 | 0.0003 | -0.0036 | 0.3137 | 5.61 | 7.64 | 214,085.70 | -272.25 | -837.07 | -- | -- | 28.37 | 39.75 | -867.96 | -3,809.92 | 0.031 | -0.6498 | -- | -- | 267.09 | 159.65 | 16.09 | -- | -- | -- |
| Windtree Therapeutics Inc | 0.00 | -20.29m | 2.21m | 15.00 | -- | 7.66 | -- | -- | -8.21 | -8.21 | 0.00 | 0.5655 | 0.00 | -- | -- | 0.00 | -57.68 | -44.51 | -63.50 | -48.38 | -- | -- | -- | -94,533.34 | -- | -- | 0.8179 | -- | -- | -- | 48.25 | -- | -- | -- |
| Dermata Therapeutics Inc | 0.00 | -7.79m | 2.27m | 8.00 | -- | 0.2104 | -- | -- | -3.89 | -3.89 | 0.00 | 1.62 | 0.00 | -- | -- | 0.00 | -104.46 | -- | -125.96 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.90 | -- | -- | -- |
| PainReform Ltd | 0.00 | -9.34m | 2.28m | 6.00 | -- | 0.2197 | -- | -- | -7.21 | -7.21 | 0.00 | 4.19 | 0.00 | -- | -- | 0.00 | -83.96 | -55.47 | -99.49 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
| CNS Pharmaceuticals Inc | 0.00 | -18.85m | 2.29m | 3.00 | -- | -- | -- | -- | -5.76 | -5.76 | 0.00 | -0.7132 | 0.00 | -- | -- | 0.00 | -255.54 | -132.47 | -1,018.78 | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
| Galmed Pharmaceuticals Ltd | 0.00 | -6.91m | 2.31m | 3.00 | -- | 0.14 | -- | -- | -3.68 | -3.68 | 0.00 | 2.75 | 0.00 | -- | -- | 0.00 | -41.65 | -45.06 | -50.55 | -50.79 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.31 | -- | -- | -- |
| Gamida Cell Ltd | 1.78m | -63.00m | 2.32m | 145.00 | -- | -- | -- | 1.30 | -0.6582 | -0.6582 | 0.0162 | -0.0204 | 0.0157 | -- | -- | 12,303.45 | -55.51 | -56.15 | -71.23 | -67.62 | 18.50 | -- | -3,531.17 | -18,390.58 | 2.09 | -- | 1.04 | -- | -- | -- | 20.63 | -- | -8.05 | -- |
| Regen BioPharma Inc | 236.58k | -851.69k | 2.35m | 1.00 | -- | -- | -- | 9.91 | -0.2271 | -0.2271 | 0.0633 | -1.26 | 0.8644 | -- | 3.98 | 236,580.00 | -327.54 | -104.36 | -- | -- | -- | -- | -378.93 | -275.00 | -- | -1.32 | -- | -- | 0.4416 | 18.79 | -58.11 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 12.31m | -5.08m | 2.39m | 9.00 | -- | 0.3131 | -- | 0.1941 | -0.9608 | -0.9608 | 1.95 | 0.489 | 0.8625 | 2.58 | 4.76 | 1,367,778.00 | -35.56 | -37.52 | -47.14 | -51.35 | 39.17 | 40.17 | -41.23 | -37.12 | 3.11 | -- | 0.0065 | -- | 5.10 | -4.44 | -1.28 | -- | 7.54 | -- |
| Resonate Blends Inc | 16.47k | -1.42m | 2.41m | 6.00 | -- | -- | -- | 146.58 | -0.0178 | -0.0178 | 0.0002 | -0.0247 | 0.0237 | -- | -- | -- | -203.52 | -680.29 | -- | -- | -593.02 | -78.88 | -8,597.33 | -12,895.26 | -- | -0.4691 | 7.89 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| Salarius Pharmaceuticals Inc | 0.00 | -12.54m | 2.52m | 2.00 | -- | 0.393 | -- | -- | -4.54 | -4.54 | 0.00 | 1.34 | 0.00 | -- | -- | 0.00 | -118.12 | -69.27 | -160.07 | -79.89 | -- | -- | -- | -675.70 | -- | -- | 0.0519 | -- | -- | -- | 60.32 | -- | -- | -- |
| Onconetix Inc | 58.47k | -37.41m | 2.52m | 12.00 | -- | -- | -- | 43.15 | -2.09 | -2.09 | 0.0034 | 2.63 | 0.001 | -- | 0.6301 | 4,872.50 | -65.73 | -- | -87.29 | -- | -1,927.76 | -- | -63,981.00 | -- | 0.3185 | -19.88 | 0.1292 | -- | -- | -- | -176.78 | -- | -- | -- |
| Qrons Inc | 0.00 | -789.36k | 2.53m | 2.00 | -- | -- | -- | -- | -0.0581 | -0.0581 | 0.00 | -0.109 | 0.00 | -- | -- | 0.00 | -45,235.53 | -1,513.45 | -- | -- | -- | -- | -- | -- | -- | -5.76 | -- | -- | -- | -- | -7.61 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Galmed Pharmaceuticals Ltd's reporting currency: US Dollar USD
14.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Heights Capital Management, Inc.as of 31 Dec 2023 | 269.24k | 7.07% |
| Walleye Capital LLCas of 31 Dec 2023 | 115.40k | 3.03% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 81.23k | 2.13% |
| Two Sigma Advisers LPas of 31 Dec 2023 | 44.43k | 1.17% |
| Two Sigma Investments LPas of 31 Dec 2023 | 23.52k | 0.62% |
| Citadel Securities LLCas of 31 Dec 2023 | 11.25k | 0.30% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 1.24k | 0.03% |
| Wells Fargo Clearing Services LLCas of 31 Dec 2023 | 204.00 | 0.01% |
| TSFG LLCas of 31 Mar 2024 | 200.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2023 | 53.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
